363 related articles for article (PubMed ID: 6427831)
21. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
22. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
Lynch MR
Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
[TBL] [Abstract][Full Text] [Related]
23. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
24. Chronic lithium treatment and dopamine-mediated behavior.
Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
[TBL] [Abstract][Full Text] [Related]
25. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
[TBL] [Abstract][Full Text] [Related]
26. Permanent haloperidol-induced dopamine receptor up-regulation in the ovariectomized rat.
Fields JZ; Gordon JH
Brain Res Bull; 1991 Apr; 26(4):549-52. PubMed ID: 1831063
[TBL] [Abstract][Full Text] [Related]
27. Ethanol reduces tolerance, sensitization, and up-regulation of D2-receptors after subchronic haloperidol.
Wolffgramm J; Rommelspacher H; Buck E
Pharmacol Biochem Behav; 1990 Aug; 36(4):907-14. PubMed ID: 2217521
[TBL] [Abstract][Full Text] [Related]
28. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
Haracz JL; Tseng LF
Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):131-3. PubMed ID: 6106902
[TBL] [Abstract][Full Text] [Related]
29. Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouse.
Feigenbaum JJ; Yanai J
Neuropharmacology; 1985 Aug; 24(8):735-41. PubMed ID: 3939327
[TBL] [Abstract][Full Text] [Related]
30. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
[TBL] [Abstract][Full Text] [Related]
32. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
Lipska BK; Weinberger DR
Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
[TBL] [Abstract][Full Text] [Related]
33. Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivity.
Jenner P; Hall MD; Murugaiah K; Rupniak N; Theodorou A; Marsden CD
Biochem Pharmacol; 1982 Feb; 31(3):325-8. PubMed ID: 7200363
[TBL] [Abstract][Full Text] [Related]
34. [Dependence of the effects of tripeptide MIF and lithium chloride on the degree of supersensitivity of dopamine receptors of the brain].
Bondarenko NA; Val'dman AV
Biull Eksp Biol Med; 1989 Aug; 108(8):196-9. PubMed ID: 2553154
[TBL] [Abstract][Full Text] [Related]
35. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity.
Rubin EH; Wooten GF
Psychopharmacology (Berl); 1984; 84(2):217-20. PubMed ID: 6438680
[TBL] [Abstract][Full Text] [Related]
36. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics.
Fields JZ; Gordon JH
Life Sci; 1982 Jan; 30(3):229-34. PubMed ID: 7200183
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of chronic clorgyline and amfonelic acid on desensitization of striatal dopamine receptors.
Meller E; Bohmaker K; Friedhoff AJ
Life Sci; 1984 Oct; 35(18):1829-38. PubMed ID: 6492992
[TBL] [Abstract][Full Text] [Related]
38. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM
Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405
[TBL] [Abstract][Full Text] [Related]
39. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
Koller W; Curtin J; Fields J
Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
[TBL] [Abstract][Full Text] [Related]
40. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
Meller E
Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]